Group 1 - Huayou Cobalt's subsidiary signed a supply agreement with LGES for 76,000 tons of ternary precursor products from 2026 to 2030, and another contract for 88,000 tons of ternary cathode materials, indicating a significant long-term partnership [1] - The collaboration between Huayou Cobalt and LGES highlights the strategic importance of Chinese material companies in the global supply chain and LGES's strategy to secure upstream resources to enhance global competitiveness [1] - The expected increase in demand for electric vehicles and energy storage solutions is likely to benefit such deep collaborations, potentially leading to growth opportunities [1] Group 2 - Fulin Precision plans to jointly increase capital in its subsidiary Jiangxi Shenghua with CATL, with Fulin investing 1 billion yuan and CATL investing 2.563 billion yuan, resulting in CATL holding a 51% stake [2] - This capital increase is a typical case of deep integration of technology and capital in the power battery industry, allowing CATL to secure core production capacity while Fulin accelerates its technological upgrades and international expansion [2] - The impact of Jiangxi Shenghua's financial performance on Fulin Precision needs to be monitored in the short term, while long-term success will depend on collaboration in new fields like robotics [2] Group 3 - Tianji Co. is advancing the industrialization of its lithium sulfide material preparation patent, with approximately 5 million yuan invested in R&D and a team of 7 researchers [3] - The project has passed initial small-scale tests, but further scaling and cost analysis are required before moving to pilot testing, indicating the early stage of development [3] - Despite the promising market for solid-state batteries, Tianji faces challenges in technology transfer, cost optimization, and shareholder dynamics, which may limit short-term contributions to performance [3]

Group 1 - Yinglian Co., Ltd. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters of 2025, representing a year-on-year increase of 1531% to 1673% [1] - China CNR Corporation signed major contracts totaling approximately 54.34 billion yuan, accounting for 22% of its expected revenue for 2024 [1] - Shengmei Shanghai reported a total order amount of 9.072 billion yuan, a year-on-year increase of 34.1% [2] Group 2 - Fulian Precision plans to increase capital in its subsidiary Jiangxi Shenghua with a total investment of 35.63 billion yuan, which is expected to constitute a major asset restructuring [3] - Aimeike has obtained a drug registration certificate for Minoxidil topical solution, which is used for treating male pattern baldness [4] - Guolin Technology is planning to acquire 91.07% of Kailianjie’s equity for cash, which is expected to constitute a major asset restructuring [5] Group 3 - Baicheng Co. plans to purchase 55% of Shanghai Canxi Engineering Equipment Co. and will suspend trading of its stock starting September 30, 2025 [6][7] - Diaowei is planning to acquire equity in Rongpai Semiconductor and has suspended trading of its stock [8] - Xiatun New Energy signed a strategic cooperation framework agreement with Zhongwei Co. to establish a long-term partnership in the supply chain for solid-state lithium battery materials [9] Group 4 - Lingyi Zhi Manufacturing is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy [10] - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, which targets cancer pain treatment [11] - Weide Information announced a preliminary transfer price of 40.33 yuan per share, representing a 26% discount to its closing price [12] Group 5 - Huayou Cobalt's subsidiary signed contracts with LGES for the supply of 76,000 tons of ternary precursor materials and 88,000 tons of ternary cathode materials from 2026 to 2030 [13] - Hubei Energy signed a cooperation agreement with the Xiangyang Municipal Government to invest 26.7 billion yuan in clean energy projects [14]

Group 1 - The core viewpoint of the article highlights the strong demand in the energy storage and solid-state battery sectors, driven by unexpected increases in lithium iron phosphate (LiFePO4) production, which is expected to boost upstream lithium salt and phosphoric chemical industries [1][10]. - According to Dongwu Securities, the shortage of energy storage cells is expected to persist until the second half of 2026, with low-priced orders seeing a price increase of 1-3 cents per watt-hour, leading to significant improvements in manufacturer profitability [2]. - The production capacity of various companies is projected to increase significantly, with notable expansions planned for companies like Hunan YN and Fulin Precision, indicating a robust growth trajectory in the energy storage market [3]. Group 2 - The A-share market experienced a collective rise, with major indices showing significant gains, particularly in the financial sector, which saw a surge in trading volume and investor confidence [10][29]. - The energy storage sector is rebounding strongly, with leading battery manufacturers reporting full production capacity and some orders extending into early next year, reflecting the ongoing demand [11]. - The satellite communication sector is also gaining traction, with major telecom companies receiving licenses to operate satellite mobile communication services, enhancing communication capabilities in various applications [14].

公司近日收到汕头天际出具的《告知函》，汕头天际于 2025 年 9 月 29 日通 过大宗交易减持 4,500,000 股，汕头天际及一致行动人星嘉国际持股占公司总股 本比例由 16.77%降至 15.87%，占公司剔除后总股本比例由 17.10%降至 16.18%， 权益变动触及 1%的整数倍，具体情况如下： | 1．基本情况 | | | --- | --- | | 信息披露义务人 | 汕头市天际有限公司 | | 住所 | 汕头市金平区大华路 76 号 2 幢 402 号房 | | 权益变动时间 | 2025 年 9 月 29 日 | | 权益变动过程 | 汕头天际于 2025 年 9 月 29 日通过大宗交易减持 4,500,000 | | | | | | 股，汕头天际及一致行动人星嘉国际持股占公司总股本比例由 | | | | --- | --- | --- | --- | --- | --- | --- | | 16.77%降至 | | | | 15.87%，占公司剔除后总股本比例由 | | 17.10%降至 | | 16.18%，权益变动触及 | 1%的整数倍。 | | | | | | | | 上述股 ...

Core Viewpoint - Tianji Co., Ltd. (002759.SZ) has experienced significant stock price fluctuations, with a cumulative increase of over 20% during the trading days of September 26 and September 29, 2025, indicating abnormal trading activity [1] Group 1: Company Developments - The company is advancing the industrialization of its lithium sulfide material preparation patent (Patent No. ZL202411448897.4), supported by a team of 7 researchers, including 3 core R&D personnel, with approximately 5 million yuan invested in R&D so far [1] - The project has successfully passed small-scale testing and will proceed to larger-scale trials to analyze cost and industrial feasibility before entering the pilot test phase to further validate production stability and equipment compatibility [1] Group 2: Risks and Challenges - The technology development is still in its early stages, and transitioning from patent to stable, mass-produced commercial products will require extensive process optimization and validation [1] - There is a potential risk that superior and lower-cost solid electrolyte technologies may undermine the competitive advantage of lithium sulfide technology in the future [1] - The industrialization process may face challenges such as consistency and stability issues during the pilot testing phase, which could lead to underperformance in commercialization [1] Group 3: Shareholder Activity - During the abnormal trading period, the controlling shareholder, Shantou Tianji, reduced its stake by selling 4.5 million shares through block trading, with the reduction plan still ongoing as of the announcement date [2] - The actual controller did not engage in buying or selling company shares during the abnormal trading period [2]

公司控股股东汕头天际于股票交易异常波动期间(2025年9月26日、2025年9月29日)通过大宗交易减持公 司股票450万股，公司已于2025年7月3日披露《关于控股股东及一致行动人减持股份预披露公告》(公告 编号：2025-042)，截至本公告披露日，本次减持计划尚未履行完毕;实际控制人在公司股票交易异常波 动期间未买卖公司股票。 智通财经APP讯，天际股份(002759.SZ)发布公告，公司股票连续二个交易日(2025年9月26日、2025年9 月29日)收盘价格涨幅偏离值累计超过20%。根据《深圳证券交易所交易规则》的有关规定，属于股票 交易异常波动的情况。 目前公司技术开发过程仍处于早期阶段，从专利到稳定、批量生产的商业化产品，需要经历漫长的工艺 优化和验证过程。如果未来出现更优越、成本更低的固态电解质技术路线，可能会削弱硫化锂技术的竞 争优势。同时产业化过程中，实验室成功的配方和工艺，在中试时经常会出现产品一致性、稳定性等方 面的问题。因此，该项目存在产业化、商用化不及预期的风险。 公司正在推动硫化锂材料制备专利(专利号：ZL202411448897.4)的产业化，该项目由7名研发人员组 成，其中核 ...

Core Viewpoint - Tianji Co., Ltd. (002759.SZ) is currently promoting the industrialization of lithium sulfide material preparation patents, having invested approximately 5 million yuan in R&D, but the project is still in its early stages and faces risks of underperformance in industrialization and commercialization [1] Group 1 - The company has announced abnormal fluctuations in its stock trading [1] - The controlling shareholder, Shantou Tianji, reduced its holdings by 4.5 million shares through block trading during the abnormal trading period on September 26 and September 29, 2025 [1] - As of the date of the announcement, the share reduction plan has not been fully executed [1]

股票代码：002759 股票简称：天际股份 公告编号：2025-061 天际新能源科技股份有限公司 关于股票交易异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、 误导性陈述或重大遗漏 一、股票交易异常波动的情况 天际新能源科技股份有限公司（以下简称"公司"）股票连续二个交易日（2025 年 9 月 26 日、2025 年 9 月 29 日）收盘价格涨幅偏离值累计超过 20%。根据《深 圳证券交易所交易规则》的有关规定，属于股票交易异常波动的情况。 二、公司关注、核实情况 针对股票交易异常波动，公司对有关事项进行了核查，并向控股股东及实际 控制人核实，不存在应披露而未披露的重大信息，现将有关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司正在推动硫化锂材料制备专利（专利号：ZL202411448897.4）的产 业化，该项目由 7 名研发人员组成，其中核心研发人员 3 名，目前已投入研发费 用约 500 万元。该项目现已基本通过小型试验，后续公司还需先进行放大试验对 候选工艺进行成本、工业难易程度分析，以确定种子工艺，再进入中试阶段对种 子工艺 ...

Group 1 - The company is currently in the early stages of technology development, transitioning from patents to stable, mass-produced commercial products [1] - The process of industrialization involves lengthy optimization and verification, which may lead to inconsistencies and stability issues during pilot testing [1] - There is a potential risk that superior and lower-cost solid electrolyte technologies could undermine the competitive advantage of lithium sulfide technology in the future [1]

Core Viewpoint - Tianji Co., Ltd. is advancing the industrialization of lithium sulfide material preparation patent (Patent No: ZL202411448897.4) with a dedicated team of 7 researchers, including 3 core members, and has invested approximately 5 million yuan in R&D costs [1][1][1] Group 1 - The project has successfully passed small-scale tests and will proceed to larger-scale trials to analyze cost and industrial feasibility of the candidate processes [1][1] - The company is in the early stages of technology development, and the transition from patent to stable, mass-produced commercial products will require extensive process optimization and validation [1][1][1] Group 2 - The project faces risks related to industrialization and commercialization not meeting expectations, urging investors to make cautious decisions [1][1][1]